Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Liverpool Launches £20 million Project to Develop Medicines for Children

07.12.2006
A £20 million Department of Health programme to develop medicines specifically for use in children will be launched jointly by the University of Liverpool and the Royal Liverpool Children’s NHS Trust (Alder Hey) tomorrow (Thursday, 7 December).

The initiative involves the establishment of a national research network to undertake important clinical studies into the safety and effectiveness of medicines for children. A consortium led by the University of Liverpool acts as the co-ordinating centre for the network, based at the Institute of Child Health at Alder Hey.

Many of the medicines used to treat children have been designed for adults and have not been properly tested on the young. Health professionals use their skill and judgement when prescribing medicines for the young but need better information from studies conducted with children to inform these decisions.

Andy Burnham, Minister of Delivery and Quality for the Department of Heath, who will formally launch the project tomorrow, said: “The Government is committed to making the UK the best place in the world for medical research and will invest over £750 million this year.

“Establishing the Medicines for Children Research Network will ensure that children benefit directly from the latest medical advances and treatments designed, developed and licensed specifically for their use.

"By bringing together the research expertise of the University of Liverpool and the world renowned children's care at Alder Hey, this initiative is a significant boost to Liverpool - putting it at the forefront of research of children's medicines in this country.”

Professor Sally C. Davies, Director General of R&D at the Department of Health said:

"This unique achievement will drive partnerships between the NHS and its young patients with top class researchers and with funding from the public, commercial and charitable sectors to meet the very specific needs of children across the entire range of health care and services. Our children are entitled to the same standards of treatment as adults and the MCRN will place this important issue at the heart of the national research effort."

The Medicines for Children Research Network (MCRN) is one of six topic-specific Research Networks which form a part of the UK Clinical Research Network, an initiative funded by the Department of Health to strengthen and facilitate clinical research across the UK with the aim of improving the quality, speed and coordination of research.

The network involves all types of health professionals, the pharmaceutical industry and most importantly, children and parents, who are helping to develop new medicines. A Young Person’s Advisory Group has been established which comprises 17 young people aged from nine to 18 who have been recruited through schools and youth organisations in Liverpool.

The group, which has named itself ‘Stand Up, Speak Up!’, will develop an understanding of the project and learn about the role of medicines in the promotion of good health.

They will work with project leaders on publicity material for children about the initiative and will act as ambassadors to encourage young people receiving medical care to participate in research projects.

Rosalind Smyth, Professor of Paediatric Medicine and director of the co-ordinating centre said: “This is the most important development towards improving children’s health that has happened during my professional career. We now have - in partnership with the pharmaceutical industry and other organisations that fund medical research - a real opportunity to provide medicines which will be of specific benefit to children.”

The MCRN will enable the development of a wide variety of drugs for children, including those for the prevention and treatment of diseases affecting newborns and children requiring intensive care. Researchers are developing treatments for a range of diseases in children such as meningitis, asthma, epilepsy and migraine.

The work of the MCRN is being undertaken by six Local Research Networks (LRNs), in England which will liaise with similar groups in the rest of the UK. These include more than 150 hospitals and Primary Care Trusts. University researchers are working jointly with the Trusts on drug development.

The Royal Liverpool Children's Hospital has been appointed as the host institution for the Cheshire, Merseyside & North Wales LRN, with Dr Matthew Peak and Dr Jo Blair as co-directors and Dr Charlie Orton as manager.

A £20 million grant will support the MCRN over five years and help to establish a world-class health service infrastructure to support clinical research and embed good clinical practice and quality in all clinical trials.

The MCRN has been developed in collaboration with the University of Liverpool; the Royal Liverpool Children’s Hospital; Imperial College, London; the Liverpool Women’s Hospital; the National Perinatal Epidemiology Unit at the University of Oxford and the National Children’s Bureau. It will be launched at Alder Hey on Thursday, 7 December.

Joanna Robotham | alfa
Further information:
http://www.liv.ac.uk

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>